Will taking Gilteritinib cause hair loss?

Gilteritinib is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia who have FLT3 mutations found in tests approved by the U.S. Food and Drug Administration (FDA). This indication is expanded to include companion diagnostics, including use with geritinib, such as the LeukoStrat CDx FLT3 mutation test. According to the drug instructions, common side effects of gilitinib include nausea, vomiting, fatigue, dizziness, etc., but hair loss is not explicitly mentioned. However, individual responses to the drug vary, and some people may experience hair loss while taking giritinib.